In vitro differentiation of adult adipose mesenchymal stem cells into retinal progenitor cells.

Autor: Moviglia GA; Center for Research in Tissue Engineering and Cellular Therapies, Maimónides University, Buenos Aires, Argentina., Blasetti N, Zarate JO, Pelayes DE
Jazyk: angličtina
Zdroj: Ophthalmic research [Ophthalmic Res] 2012; Vol. 48 Suppl 1, pp. 1-5. Date of Electronic Publication: 2012 Aug 21.
DOI: 10.1159/000339839
Abstrakt: Introduction: It has been previously shown that adult mesenchymal stem cells (MSCs) differentiate into neural progenitor cells (NPCs) and that the differentiation process was completed in 24-48 h. In this previous study, MSCs from a bone marrow or fat source were co-incubated with homologous autoaggressive cells (ECs) against nerve tissue, and these NPCs were successfully used in human regenerative therapeutic approaches. The present study was conducted to investigate whether a similar differentiation method could be used to obtain autologous retinal progenitor cells (RPCs).
Methods: Human Th1 cells against retinal tissue were obtained by challenging human blood mononuclear cells with an eye lysate of bovine origin; negative selection was performed using a specific immunomagnetic bead cocktail. Fat MSCs were obtained from a human donor through mechanical and enzymatic dissociation of a surgical sample. The ECs and MSCs were co-cultured in a serum-free medium without the addition of cytokines for 0, 24, 48 and 72 h. The plastic adherent cells were morphologically examined using inverted-phase microscopy and characterized by immunofluorescent staining using antibodies against Pax 6, TUBB3, GFAP, Bestrophin 2, RPE 65, OPN1 SW, and rhodopsin antigens.
Results: The early signs of MSC differentiation into RPCs were observed at 24 h of co-culture, and the early differentiated retinal linage cells appeared at 72 h (neurons, rods, Müller cells, retinal ganglion cells and retinal pigmented epithelial cells). These changes increased during further culture.
Conclusion: The results reported here support the development of a method to obtain a large number of autologous adult RPCs, which could be used to treat different retinopathies.
(Copyright © 2012 S. Karger AG, Basel.)
Databáze: MEDLINE